CORDA Investment Management LLC. acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 215,229 shares of the financial services provider's stock, valued at approximately $47,529,000. CME Group comprises about 2.9% of CORDA Investment Management LLC.'s investment portfolio, making the stock its 14th largest position. CORDA Investment Management LLC. owned 0.06% of CME Group at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. Asset Dedication LLC increased its position in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after purchasing an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC grew its stake in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider's stock valued at $3,147,000 after buying an additional 37 shares in the last quarter. Rehmann Capital Advisory Group grew its stake in shares of CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider's stock valued at $243,000 after buying an additional 37 shares in the last quarter. Endowment Wealth Management Inc. increased its holdings in CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider's stock worth $244,000 after buying an additional 38 shares during the last quarter. Finally, NBT Bank N A NY increased its holdings in CME Group by 2.3% in the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider's stock worth $492,000 after buying an additional 38 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Analyst Upgrades and Downgrades
CME has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on shares of CME Group from $342.00 to $322.00 and set a "buy" rating for the company in a research note on Thursday, April 23rd. Morgan Stanley lifted their price objective on shares of CME Group from $324.00 to $330.00 and gave the company an "overweight" rating in a research note on Thursday, July 23rd. Weiss Ratings cut shares of CME Group from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday. JPMorgan Chase & Co. increased their target price on shares of CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research report on Thursday, July 23rd. Finally, Erste Group Bank lowered CME Group from a "buy" rating to a "hold" rating in a report on Friday, June 5th. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $291.81.
Read Our Latest Report on CME
CME Group Price Performance
Shares of CME Group stock opened at $269.80 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a fifty day simple moving average of $250.20 and a 200-day simple moving average of $280.22. The stock has a market capitalization of $97.01 billion, a price-to-earnings ratio of 22.88, a PEG ratio of 3.14 and a beta of 0.23. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group's revenue was up .8% compared to the same quarter last year. During the same period last year, the business posted $2.96 EPS. On average, sell-side analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 44.11%.
Insider Transactions at CME Group
In other CME Group news, Director William R. Shepard acquired 325 shares of the company's stock in a transaction dated Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director owned 260,442 shares of the company's stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the business's stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company's stock, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.